Brainspotting is NOT Currently Recognized as an Evidence-Based Treatment for Trauma
Based on current clinical practice guidelines, brainspotting should not be recommended as a first-line therapeutic modality, as it lacks the rigorous evidence base required for evidence-based trauma treatment. The most authoritative trauma treatment guidelines explicitly identify cognitive behavioral therapies (particularly exposure therapy, cognitive therapy, and EMDR) and SSRIs as the only interventions with demonstrated efficacy for trauma-related conditions 1, 2.
What the Guidelines Actually Recommend
The 2021 AAP guidelines on trauma-informed care clearly state that "the most effective therapies are evidence-based treatments (EBTs) with demonstrated efficacy for children who have experienced trauma" and that "treatments that are designated as evidence based have had the most rigorous evaluation" 1. Brainspotting is notably absent from these recommendations.
The 2005 Neuropsychopharmacology consensus guidelines on post-trauma interventions provide specific efficacy data for established treatments 2:
- Exposure therapy: 40-87% of participants no longer meet PTSD criteria after 9-15 sessions
- Cognitive therapy: 53-65% recovery rates
- SSRIs (sertraline, paroxetine): 53-85% classified as treatment responders
- EMDR: Mentioned as having "scientific examination" but with less robust evidence than traditional CBT
Brainspotting is not mentioned in any established treatment guidelines.
The Limited Research on Brainspotting
The only available research on brainspotting consists of:
One small comparative study 3 with 40 psychologists/physicians (not patients) using a within-subject design for distressing memories (not clinical PTSD). While this showed some benefit, it was a single 40-minute session in a non-clinical sample—far from the rigorous multi-site randomized controlled trials required for evidence-based designation.
Two theoretical hypothesis papers 4, 5 that propose neurobiological mechanisms but provide no clinical outcome data. These are speculative frameworks, not evidence of efficacy.
Critical Distinctions
Evidence-based vs. evidence-informed: The AAP guidelines distinguish between treatments with "the most rigorous evaluation" versus "newly emerging practices that are building evidence support to less rigorously studied tools" 1. Brainspotting falls into the latter category at best, and more accurately lacks sufficient evidence to be classified as evidence-informed.
Common pitfall: Patients and some practitioners may confuse theoretical plausibility or anecdotal reports with actual evidence of efficacy. The neurobiological hypotheses proposed for brainspotting 4, 5 do not constitute proof of clinical effectiveness.
Clinical Recommendation
For patients seeking trauma treatment, recommend:
- First-line: Trauma-focused CBT (exposure therapy, cognitive processing therapy) or SSRIs (sertraline, paroxetine) 2
- Alternative evidence-based option: EMDR, which has more established research support
- Avoid: Brainspotting as a primary treatment modality given the lack of rigorous evidence
If a patient specifically requests brainspotting, explain that it lacks the evidence base of established treatments and that choosing an unproven therapy over evidence-based options could delay effective treatment and prolong suffering. The guidelines emphasize that having evidence-based services available through "warm handoff" to qualified mental health providers is the most effective approach 1.